Cutaneous fungal infections that generally require systemic antifungal therapy include tinea capitis and onychomycosis. Tinea capitis, which is most often caused by Trichophyton tonsurans ...

Anti-Fungal Therapy Market. The global anti-fungal therapy market is set to experience significant growth, with a projected ...

Antifungal dietary supplements can aid in combating fungal infections within the body. Various factors, such as a compromised immune system, poor hygiene, and exposure to contaminated environments ...

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...

More than half of the topical antifungal prescriptions in the United States in 2023 may have been unnecessary, and only 16% ...

An often-overlooked mechanism of gene regulation may be involved in the failure of antifungal drugs in the clinic. This has been discovered by a German-Austrian research team led by the Leibniz ...

Agrichemical antifungal use is leading to fungi that can evolve resistance to novel drugs faster - even those not even on the market yet ...

The Manchester-based company said the new cash will help it to complete the late-stage development of olorofim, a novel oral antifungal for invasive aspergillosis and other serious fungal ...

Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with ...